CACNG1
Voltage-dependent calcium channel gamma-1 subunit
Also known as: CACNLG, CCG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q06432
- Gene
- CACNG1
- Ensembl
- ENSG00000108878
- Chromosome
- 17
- Canonical length
- 222 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Voltage-dependent calcium channels are composed of five subunits. The protein encoded by this gene represents one of these subunits, gamma, and is one of two known gamma subunit proteins. This particular gamma subunit is part of skeletal muscle 1,4-dihydropyridine-sensitive calcium channels and is an integral membrane protein that plays a role in excitation-contraction coupling. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family and is located in a cluster with two family members that function as transmembrane AMPA receptor regulatory proteins (TARPs). [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>Q06432|CACNG1
1 MSQTKMLKVR VTLFCILAGI VLAMTAVVTD HWAVLSPHME HHNTTCEAAH FGLWRICTKR
61 IPMDDSKTCG PITLPGEKNC SYFRHFNPGE SSEIFEFTTQ KEYSISAAAI AIFSLGFIIL
121 GSLCVLLSLG KKRDYLLRPA SMFYAFAGLC ILVSVEVMRQ SVKRMIDSED TVWIEYYYSW
181 SFACACAAFI LLFLGGLALL LFSLPRMPRN PWESCMDAEP EHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CACNG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 312 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 312 nTPM
- tongue: 114 nTPM
- esophagus: 3.8 nTPM
- salivary gland: 3 nTPM
- basal ganglia: 2.2 nTPM
- adrenal gland: 1.6 nTPM
Single-cell type
- myonuclei: 127 nCPM
- thymic myoid cells: 118 nCPM
- myosatellite cells: 4.7 nCPM
- adipocytes: 3.1 nCPM
- fibro-adipogenic progenitors: 2.4 nCPM
- cardiomyocytes: 2.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 1.7 nTPM
- amygdala: 1.3 nTPM
- thalamus: 1 nTPM
- cerebral cortex: 0.8 nTPM
- hippocampal formation: 0.6 nTPM
- hypothalamus: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- establishment of localization in cell
- positive regulation of muscle contraction
- regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
- sarcoplasmic reticulum calcium ion transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PMP-22/EMP/MP20/Claudin
- Voltage-dependent calcium channel, gamma subunit
- PMP-22/EMP/MP20/Claudin tight junction
- Voltage-dependent calcium channel, gamma-1 subunit
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CACNG1 as an antibody target. Whether an autoantibody or antibody against CACNG1 could matter depends on whether native CACNG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CACNG1 is annotated at the cell surface, where native CACNG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CACNG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...